WPW Syndrome: Why Pre-Excited AF Changes Treatment
Why does pre-excited atrial fibrillation change WPW treatment?
Wolff-Parkinson-White involves an accessory electrical connection between atria and ventricles. It allows ventricular activation outside the usual AV-node route and also supports reentry rhythms. The dangerous distinction in this lesson is atrial fibrillation with pre-excitation, where AV-nodal blocking drugs risk very rapid conduction through the accessory pathway. Identify the actual rhythm before choosing treatment.
Key takeaways
- An accessory pathway changes how atrial impulses reach the ventricles.
- Short PR and a delta wave are classic signs of ventricular pre-excitation.
- Avoid extending the pre-excited-AF drug warning to every rhythm in every patient with WPW.
What does the accessory pathway change?
The AV node normally delays conduction between the atria and ventricles. An accessory pathway creates another connection. If it conducts forward, part of the ventricle activates early, producing pre-excitation.
The classic resting ECG pattern includes a short PR interval and a delta wave, the slurred initial portion of the QRS. An accessory pathway also forms part of a reentry circuit. The resting pattern and the rhythm occurring now are related pieces of information, rather than the same diagnosis.
Why is atrial fibrillation with pre-excitation dangerous?
Atrial fibrillation generates rapid, disorganized atrial impulses. An accessory pathway conducts some impulses to the ventricles without the AV node’s usual rate-limiting behavior. The resulting ventricular rhythm becomes very fast and risks deterioration into ventricular fibrillation.
AV-nodal blockers are avoided in this setting. Current AHA guidance also excludes IV amiodarone for pre-excited AF or flutter. The reason is the rhythm and conduction pathway, rather than a rule based only on seeing the letters WPW in the history.
How does this differ from other reentry rhythms?
In orthodromic AV reentrant tachycardia, the circuit commonly travels forward through the AV node and returns through the accessory pathway. This differs from atrial fibrillation conducting through that pathway. The mechanism affects the treatment options.
When explaining WPW in an interview, identify whether you are describing resting pre-excitation, a regular reentry tachycardia or pre-excited AF. The Short focuses on the last situation. A rapidly deteriorating rhythm requires immediate rhythm-appropriate electrical treatment. A mechanism discussion should never delay that response.
